Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Nov 14, 2007 by Edgar Snyder

Avandia Gets Heart Attack Warning Label

Avandia

The label of the diabetes drug, Avandia, has been strengthened even further to include a warning about the risk of heart attack. The Food and Drug Administration (FDA) has added to its already strong warning for Avandia, which carries a label that was updated to include risk of heart failure earlier this year.

In August 2007, two leading diabetes drugs, Avandia and Actos, received a black box label, the FDA’s strongest warning label possible. But those label updates only included a warning for risk of heart failure. Risk of heart attack has now been added to Avandia, along with the labels for Avandamet and Avandaryl. Actos will not receive the heart attack risk to its black box label.

Sales of Avandia have shot down nearly 50 percent since this May, when studies pointed to serious heart risks. Medical experts, as well as some FDA affiliates, have speculated that Avandia should be recalled. However, an FDA panel vote ruled 22-1 in favor of letting Avandia remain on the market.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Maryland, Ohio, Virginia, and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "FDA Strengthens Warning On GlaxoSmithKline's Avandia." By Jennifer Corbett Dooren. Wall Street Journal. November 14, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet